Wolverine Asset Management LLC Amgen Inc Transaction History

Wolverine Asset Management LLC

$6.43 Billion
Q3 2025

A detailed history of Wolverine Asset Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Wolverine Asset Management LLC holds 5,000 shares of AMGN stock, worth $1.46 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

5,000

Previous 4,900 2.04%

Holding current value

$1.46 Million

Previous $1.37 Million 3.14%

% of portfolio

0.02%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 28, 2025	SELL	$271.18 - $309.22 $843,369 - $961,674	-3,110 Reduced 49.75%	3,141 $886,000
Q2 2025 Aug 04, 2025	BUY	$262.28 - $309.85 $657,011 - $776,174	2,505 Added 66.87%	6,251 $1.75 Million
Q1 2025 May 12, 2025	SELL	$258.59 - $327.36 $1.83 Million - $2.31 Million	-7,058 Reduced 65.33%	3,746 $1.17 Million
Q4 2024 Feb 03, 2025	BUY	$258.78 - $328.31 $1.42 Million - $1.8 Million	5,473 Added 102.66%	10,804 $2.82 Million
Q3 2024 Nov 04, 2024	SELL	$309.38 - $337.38 $2.46 Million - $2.69 Million	-7,966 Reduced 59.91%	5,331 $1.72 Million
Q2 2024 Aug 01, 2024	SELL	$262.75 - $319.31 $319,504 - $388,280	-1,216 Reduced 8.38%	13,297 $4.15 Million
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $3.9 Million - $4.71 Million	14,513 New	14,513 $4.13 Million
Q2 2023 Aug 07, 2023	BUY	$214.27 - $253.37 $4.68 Million - $5.53 Million	21,826 Added 133.26%	38,204 $8.48 Million
Q1 2023 May 08, 2023	BUY	$225.79 - $275.2 $3.7 Million - $4.51 Million	16,378 New	16,378 $3.96 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $31,533 - $34,983	-135 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $28,182 - $32,842	127 Added 1587.5%	135 $33,000
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $1,731 - $2,061	8 New	8 $1,000
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $2,346 - $2,609	-10 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $1,978 - $2,427	10 New	10 $2,000
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $75,082 - $99,580	-412 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $77,954 - $100,198	412 New	412 $99,000
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $19,084 - $21,515	-103 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $1.71 Million - $1.92 Million	-10,300 Reduced 99.01%	103 $19,000
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $55.6 Million - $65 Million	-328,420 Reduced 96.93%	10,403 $1.77 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $56.3 Million - $62.9 Million	333,410 Added 6159.43%	338,823 $58.9 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $865,391 - $988,043	5,173 Added 2155.42%	5,413 $1.01 Million
Q2 2017 Aug 14, 2017	BUY	N/A	240	240 $41,000

Others Institutions Holding AMGN

# of Institutions

3,281

Shares Held

440M

Call Options Held

6.15M

Put Options Held

7.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $156B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.

Account

Wolverine Asset Management LLC Amgen Inc Transaction History